Datscan 74 MBq Solution is a Health Canada–registered radiopharmaceutical drug (DIN 02470624) held by Ge Healthcare Canada Inc, containing Ioflupane (123i). Health Canada lists its status as Marketed (status date 15 Nov 2018). Nexara Health has matched 28 registrations of Ioflupane (123i) across 9 other regulated markets.
Health Canada registration
| DIN | 02470624 |
|---|---|
| Brand name | Datscan |
| Active ingredient | Ioflupane (123i) |
| Strength | 74 MBq |
| Dosage form | Solution |
| Route | Intravenous |
| Company | Ge Healthcare Canada Inc |
| Status | Marketed — 15 Nov 2018 |
| Class | Radiopharmaceutical |
| ATC | V09AB03 IODINE IOFLUPANE 123 I |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Ioflupane (123i) registered in other markets
28 registrations of the same molecule in 9 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Croatia | DaTSCAN | GE Healthcare B.V. | otop. za inj., boč. stakl. 1x10 ml s 5 ml otop. (74 MBq/ml) | HZZO | ||
| Croatia | DaTSCAN | GE Healthcare B.V. | otop. za inj., boč. stakl. 1x10 ml s 2,5 ml otop. (74 MBq/ml) | HZZO | ||
| Czech Republic | Datscan | — | 74MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Datscan | — | 74MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Joflupan (123i) Rotop | — | 74MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Striascan | — | 74MBQ/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Striascan | — | 74MBQ/ML | Inj Sol | R | SUKL DLP |
| Denmark | Celsunax | Pinax Pharma GmbH | 74 MBq/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Striascan | CIS bio international | 74 MBq/ml | injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| European Union (EMA) | Celsunax | Pinax Pharma GmbH | Authorised | EMA centrally authorised | ||
| European Union (EMA) | DaTSCAN | GE Healthcare B.V. | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Striascan | CIS bio international | Authorised | EMA centrally authorised | ||
| Finland | Celsunax | Pinax Pharma GmbH | 74 MBq/ml | injektioneste, liuos | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | DaTSCAN | GE Healthcare B.V. | 74 MBq/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Joflupaani (123I) Rotop | ROTOP Radiopharmacy GmbH | 74 MBq/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Striascan | CIS bio international | 74 MBq/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Ireland | Celsunax 74 MBq/mL solution for injection | Pinax Pharma GmbH | Solution for injection | Unknown | HPRA | |
| Ireland | DaTSCAN 74 MBq/ml solution for injection | GE Healthcare B.V. | Solution for injection | Unknown | HPRA | |
| Ireland | Striascan 74 MBq /mL solution for injection | CIS bio International | Solution for injection | Unknown | HPRA | |
| Poland | Celsunax | Pinax Pharma GmbH | 74 MBq/ml | Roztwór do wstrzykiwań | URPL RPL | |
| Poland | DaTSCAN | GE Healthcare B.V. | 74 MBq/ml | Roztwór do wstrzykiwań | URPL RPL | |
| Poland | Ioflupane (123I) ROTOP | ROTOP Radiopharmacy GmbH | 74 MBq/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Striascan | Cis bio international B.P. | 74 MBq/ml | Roztwór do wstrzykiwań | URPL RPL | |
| Romania | DATSCAN 74 MBq/ml | — | 74 MBq/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | DATSCAN 74 MBq/ml | — | 74 MBq/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | STRIASCAN 74 MBq/ml | — | 74MBq/ml | Sol Inj. | PR | ANMDMR nomenclator |
| Romania | STRIASCAN 74 MBq/ml | — | 74MBq/ml | Sol Inj. | PR | ANMDMR nomenclator |
| Singapore | Datscan Solution For Injection 74 Mbq/mL | Ge Healthcare Pte. Ltd. | 74 MBq/mL at reference time | Injection, Solution | Prescription Only | HSA |
See every manufacturer of Ioflupane (123i) worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Datscan (DIN 02470624) marketed in Canada?
Yes. Health Canada lists DIN 02470624 as Marketed as of 15 Nov 2018.
Who holds the Canadian licence for this product?
Ge Healthcare Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Ioflupane (123i) registered outside Canada?
Yes — Nexara Health has matched 28 registrations in 9 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02470624, status date 2018-11-15; national medicine registries: ANMDMR nomenclator, EMA centrally authorised, Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, SUKL DLP, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02470624, status date 2018-11-15; national medicine registries: ANMDMR nomenclator, EMA centrally authorised, Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, SUKL DLP, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02470624, status date 2018-11-15; national medicine registries: ANMDMR nomenclator, EMA centrally authorised, Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, SUKL DLP, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.